Last reviewed · How we verify
NCT06890468
Three-in-One Stop Computed Topography Angiography(CTA) and CT Perfusion(CTP) in Cerebrovascular Disease
trial in Radiology in 1,000 participants. Not yet recruiting.
30 December 2029
Quick facts
| Lead sponsor | Xin Lou |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 16 March 2025 |
| Primary completion | 30 December 2029 |
| Estimated completion | 30 December 2029 |
| Sites | 1 location across China |
Conditions studied
- Radiology — all drugs for Radiology →
- Vascular Diseases — all drugs for Vascular Diseases →
Sponsor
Xin Lou
Who can join
Adults 18 to 100, any sex, with Radiology or Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research takes patients with cerebrovascular diseases as the research subjects and employs the experimental design of a prospective cohort study, aiming to innovatively develop and validate a "one-stop" multimodal CT examination scheme. The 301-CTAP multimodal CT technique implies that three modalities are acquired through a single collection, including head and neck CTA (head and neck CTA), multiphase CTA imaging of the brain (multiphase CTA), and CT perfusion imaging of the brain (CT perfusion).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06890468
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Radiology
Currently open trials in the same condition.
- NCT07087418 — AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases · recruiting
- NCT06356831 — National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis · recruiting
- NCT06612697 — Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy Alone · active not recruiting
- NCT07214363 — The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers · NA · active not recruiting
- NCT05614193 — Deep Enhanced Imaging in Stroke and Vascular Neurology · recruiting
Other Xin Lou trials
Trials by the same sponsor.
- NCT06589843 — Artificial Intelligent Image Processing and Diagnosis of Pulmonary Vessels in CT · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06890468 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xin Lou
- Last refreshed: 24 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06890468.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing